YU7504A - Postupak za kultivisanje ćelija u mono sloju - Google Patents
Postupak za kultivisanje ćelija u mono slojuInfo
- Publication number
- YU7504A YU7504A YU7504A YUP7504A YU7504A YU 7504 A YU7504 A YU 7504A YU 7504 A YU7504 A YU 7504A YU P7504 A YUP7504 A YU P7504A YU 7504 A YU7504 A YU 7504A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- medium
- culture
- cell
- culturing cells
- monolayer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Postupak za kultivisanje ćelija u monosloju koji obuhvata a) zasejavanje posude za kulturu ćelijskom šaržom u minimalnom ili bogatom medijumu i dopuštanje da ćelije rastu u toku 24-72 sata; b) uklanjanje medijuma iz kuklture iz stupnja a) i zamena sa svežim, bogatim medijumom, dopunjenim sa optimiziranom koncentracijom lipida i opciono takodje uključujući dodatak seruma; c) rast kulture ćelija u bogatom medijumu dopunjen sa lipidom; d) opciono zamenjivanje medijuma iz stupnja c) sa svežim medijumom koji ne sadrži dodatak lipida posle oko 24-72 sata rasta.[Process for culturing cells in a monolayer includes a) sowing the cell into the container for culture in minimal or rich medium and allowing the cell to grow during 24-72 hours; b) removing the medium from the culture from the stage a) and replacement thereof by a fresh, rich medium, enriched by the optimal concentration of lipids and optionally also include enrichment by a serum; c) the growth of the cell culture in rich medium enriched by lipid; d) optional replacement of medium from the stage c) with a fresh medium that contains no lipid residues upon approximately around 24-72 hours of growing.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89403992A | 1992-06-04 | 1992-06-04 | |
| US07/893,295 US5360736A (en) | 1992-06-04 | 1992-06-04 | Process for attenuated varicella zoster virus vaccine production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU7504A true YU7504A (sh) | 2006-08-17 |
| RS50330B RS50330B (sr) | 2009-11-10 |
Family
ID=27129046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU38893A YU49210B (sh) | 1992-06-04 | 1993-06-02 | Postupak za proizvodnju oslabljene varičela zoster virus vakcine |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU38893A YU49210B (sh) | 1992-06-04 | 1993-06-02 | Postupak za proizvodnju oslabljene varičela zoster virus vakcine |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5607852A (sh) |
| EP (2) | EP0573107B1 (sh) |
| JP (2) | JP2599552B2 (sh) |
| KR (1) | KR100350169B1 (sh) |
| CN (2) | CN1069216C (sh) |
| AT (2) | ATE419332T1 (sh) |
| AU (2) | AU4392193A (sh) |
| BG (1) | BG62176B1 (sh) |
| CA (1) | CA2097019C (sh) |
| CZ (2) | CZ289574B6 (sh) |
| DE (2) | DE69330850T2 (sh) |
| DK (2) | DK1097988T3 (sh) |
| ES (2) | ES2317869T3 (sh) |
| FI (1) | FI117758B (sh) |
| GR (1) | GR3036812T3 (sh) |
| HU (1) | HU220080B (sh) |
| MX (1) | MX9303274A (sh) |
| NO (1) | NO314068B1 (sh) |
| NZ (1) | NZ253527A (sh) |
| PT (2) | PT573107E (sh) |
| RO (1) | RO114906B1 (sh) |
| RS (1) | RS50330B (sh) |
| RU (1) | RU2126269C1 (sh) |
| SK (1) | SK279387B6 (sh) |
| TW (1) | TW349868B (sh) |
| UA (1) | UA27137C2 (sh) |
| WO (1) | WO1993024616A1 (sh) |
| YU (1) | YU49210B (sh) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2361495A (en) | 1994-04-28 | 1995-11-29 | Aviron | A novel vzv gene, mutant vzv and immunogenic compositions |
| KR0177323B1 (ko) * | 1996-02-16 | 1999-04-01 | 성재갑 | 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법 |
| US20040171152A1 (en) * | 1996-10-10 | 2004-09-02 | Invitrogen Corporation | Animal cell culture media comprising non-animal or plant-derived nutrients |
| EP1983044B1 (en) * | 1996-10-10 | 2016-08-10 | Life Technologies Corporation | Animal cell culture media comprising plant-derived nutrients |
| GB9716611D0 (en) * | 1997-08-07 | 1997-10-08 | Cantab Pharmaceuticals Res Ltd | Virus preparations and methods |
| US6210683B1 (en) | 1997-09-05 | 2001-04-03 | Merck & Co., Inc. | Stabilizers containing recombinant human serum albumin for live virus vaccines |
| GB9804632D0 (en) | 1998-03-05 | 1998-04-29 | Cantab Pharma Res | Virus preparations and methods |
| KR100378909B1 (ko) * | 1998-03-18 | 2003-12-18 | 주식회사 엘지생명과학 | 사람세포주를이용한풍진백신의생산수율증대방법 |
| GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
| WO1999057246A1 (en) * | 1998-05-01 | 1999-11-11 | Life Technologies, Inc. | Animal cell culture media comprising non-animal or plant-derived nutrients |
| US20060286668A1 (en) * | 1999-04-30 | 2006-12-21 | Invitrogen Corporation | Animal-cell culture media comprising non-animal or plant-derived nutrients |
| DE60124984T2 (de) * | 2000-01-31 | 2007-09-20 | The Research Foundation For Microbial Diseases Of Osaka University, Suita | Verfahren zum kontrollieren der qualität eines abgeschwächten varicella phasen-impfstoffes |
| CN1318580C (zh) * | 2003-07-10 | 2007-05-30 | 北京科兴生物制品有限公司 | 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法 |
| US7344839B2 (en) * | 2004-12-23 | 2008-03-18 | Aurx, Inc. | Virus preparations and methods |
| US20100184190A1 (en) * | 2006-10-17 | 2010-07-22 | Medimmune, Llc | Influencing viral lipid constituents |
| US20080294361A1 (en) * | 2007-05-24 | 2008-11-27 | Popp Shane M | Intelligent execution system for the monitoring and execution of vaccine manufacturing |
| EP2310495B1 (en) * | 2008-08-11 | 2017-11-22 | Sanofi Pasteur Biologics, LLC | Compositions and methods for the production of alpha-herpesvirus 2 |
| CN101967466A (zh) | 2009-07-28 | 2011-02-09 | 新泽西医学院 | Orf7缺陷型水痘病毒株、含有该毒株的疫苗及其应用 |
| FR2952825B1 (fr) | 2009-11-24 | 2012-05-25 | Goaster Jacqueline Le | Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2 |
| CN101972474B (zh) * | 2010-11-11 | 2012-06-27 | 长春祈健生物制品有限公司 | 冻干带状疱疹减毒活疫苗及制备方法 |
| RU2580003C2 (ru) * | 2011-02-24 | 2016-04-10 | Могам Байотекнолоджи Рисерч Инститьют | Новые штаммы вируса ветряной оспы и противовирусная вакцина против ветряной оспы и опоясывающего лишая, в которой применяются такие штаммы |
| WO2014062060A1 (en) * | 2012-10-18 | 2014-04-24 | Erasmus University Medical Center Rotterdam | New method for producing high titer cell-free vzv vaccine virus |
| CN103074304B (zh) * | 2013-01-28 | 2016-01-13 | 江苏健安生物科技有限公司 | 高水平人二倍体细胞培养水痘-带状疱疹疫苗病毒方法 |
| US10350289B2 (en) | 2013-09-05 | 2019-07-16 | Merck Sharp & Dohme Corp. | Methods of immunization with varicella zoster virus antigen |
| CN103740735B (zh) * | 2013-12-31 | 2016-04-06 | 李越希 | 化学合成的HSV2病毒gC糖蛋白胞外区基因片段及其表达、应用 |
| US10517943B2 (en) * | 2014-12-01 | 2019-12-31 | Transgene S.A. | Stable liquid vaccinia virus formulations |
| RU2637093C1 (ru) * | 2016-12-20 | 2017-11-29 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) | Способ получения живой культуральной аттенуированной вакцины для профилактики ветряной оспы |
| CN107174658B (zh) * | 2017-04-29 | 2020-11-27 | 安徽智飞龙科马生物制药有限公司 | 人用水痘病毒灭活疫苗及其制备方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3660565A (en) * | 1968-04-17 | 1972-05-02 | Wistar Inst | Rubella vaccine and method |
| US3555149A (en) * | 1968-07-05 | 1971-01-12 | Merck & Co Inc | Mumps vaccine and its preparation |
| US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
| US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
| JPS5341202B2 (sh) * | 1974-03-12 | 1978-11-01 | ||
| US3961046A (en) * | 1974-12-02 | 1976-06-01 | American Cyanamid Company | Mumps vaccine and preparation thereof |
| US4000256A (en) * | 1975-04-30 | 1976-12-28 | Merck & Co., Inc. | Varicella vaccine and process for its preparation |
| GB1481650A (en) * | 1975-05-06 | 1977-08-03 | Merck & Co Inc | Chemical processes and products |
| JPS5251009A (en) * | 1975-10-17 | 1977-04-23 | Morinaga Milk Ind Co Ltd | Method of producing drug for treating marrow leukemia |
| US4147772A (en) * | 1976-02-03 | 1979-04-03 | Merck & Co., Inc. | Vaccine stabilizer |
| JPS5341202A (en) * | 1976-09-28 | 1978-04-14 | Fuji Photo Film Co Ltd | Novel magnetic recording medium |
| JPS55147227A (en) * | 1979-05-04 | 1980-11-17 | Handai Biseibutsubiyou Kenkyukai | Preparrtion of attenuated live mumps vaccine |
| US4252792A (en) * | 1979-09-21 | 1981-02-24 | Douglas Industries, Inc. | Injectable rabies vaccine composition and method for preparing same |
| US4273762A (en) * | 1979-12-03 | 1981-06-16 | Merck & Co., Inc. | Lyophilization process for live viral compositions |
| US4337242A (en) * | 1980-02-05 | 1982-06-29 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
| US4338335A (en) * | 1980-02-05 | 1982-07-06 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
| US4772466A (en) * | 1983-08-22 | 1988-09-20 | Syntex (U.S.A.) Inc. | Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants |
| JPS624370A (ja) * | 1985-07-01 | 1987-01-10 | Sharp Corp | 半導体素子 |
| US5024836A (en) * | 1987-05-04 | 1991-06-18 | Merck & Co., Inc. | Stable lyophilized live herpes virus vaccine |
| WO1990003429A1 (en) * | 1988-09-23 | 1990-04-05 | Cetus Corporation | Lipid microemulsions for culture media |
| US5360736A (en) * | 1992-06-04 | 1994-11-01 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
-
1993
- 1993-05-26 CA CA002097019A patent/CA2097019C/en not_active Expired - Lifetime
- 1993-05-26 UA UA94129122A patent/UA27137C2/uk unknown
- 1993-05-26 AU AU43921/93A patent/AU4392193A/en not_active Abandoned
- 1993-05-26 RO RO94-01924A patent/RO114906B1/ro unknown
- 1993-05-26 KR KR1019940704393A patent/KR100350169B1/ko not_active IP Right Cessation
- 1993-05-26 CZ CZ19943045A patent/CZ289574B6/cs not_active IP Right Cessation
- 1993-05-26 SK SK1480-94A patent/SK279387B6/sk not_active IP Right Cessation
- 1993-05-26 US US08/347,345 patent/US5607852A/en not_active Expired - Lifetime
- 1993-05-26 RU RU94046296A patent/RU2126269C1/ru active
- 1993-05-26 NZ NZ253527A patent/NZ253527A/en not_active IP Right Cessation
- 1993-05-26 HU HU9403473A patent/HU220080B/hu unknown
- 1993-05-26 WO PCT/US1993/004986 patent/WO1993024616A1/en active IP Right Grant
- 1993-05-27 PT PT93201521T patent/PT573107E/pt unknown
- 1993-05-27 EP EP93201521A patent/EP0573107B1/en not_active Expired - Lifetime
- 1993-05-27 ES ES01200292T patent/ES2317869T3/es not_active Expired - Lifetime
- 1993-05-27 AT AT01200292T patent/ATE419332T1/de active
- 1993-05-27 DK DK01200292T patent/DK1097988T3/da active
- 1993-05-27 EP EP01200292A patent/EP1097988B1/en not_active Expired - Lifetime
- 1993-05-27 ES ES93201521T patent/ES2161702T3/es not_active Expired - Lifetime
- 1993-05-27 DE DE69330850T patent/DE69330850T2/de not_active Expired - Lifetime
- 1993-05-27 DE DE69334254T patent/DE69334254D1/de not_active Expired - Lifetime
- 1993-05-27 DK DK93201521T patent/DK0573107T3/da active
- 1993-05-27 PT PT01200292T patent/PT1097988E/pt unknown
- 1993-05-27 AT AT93201521T patent/ATE206311T1/de active
- 1993-05-27 TW TW082104197A patent/TW349868B/zh not_active IP Right Cessation
- 1993-06-01 MX MX9303274A patent/MX9303274A/es unknown
- 1993-06-02 YU YU38893A patent/YU49210B/sh unknown
- 1993-06-03 CN CN93106673A patent/CN1069216C/zh not_active Expired - Lifetime
- 1993-06-03 AU AU40036/93A patent/AU673167B2/en not_active Expired
- 1993-06-04 JP JP5134711A patent/JP2599552B2/ja not_active Expired - Lifetime
-
1994
- 1994-12-01 BG BG99227A patent/BG62176B1/bg unknown
- 1994-12-02 NO NO19944654A patent/NO314068B1/no not_active IP Right Cessation
- 1994-12-02 FI FI945697A patent/FI117758B/fi not_active IP Right Cessation
-
1996
- 1996-10-02 JP JP26218596A patent/JP3156962B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-29 CZ CZ19981319A patent/CZ289690B6/cs not_active IP Right Cessation
-
2000
- 2000-10-05 CN CN00133104A patent/CN1307902A/zh active Granted
-
2001
- 2001-10-05 GR GR20010401425T patent/GR3036812T3/el unknown
-
2004
- 2004-01-26 RS YUP-75/04(62)P-388/93A patent/RS50330B/sr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU7504A (sh) | Postupak za kultivisanje ćelija u mono sloju | |
| EA199800835A1 (ru) | Среда для культуры клеток млекопитающихся, способ ее получения и смесь компонентов, композиция, способы получения, продуцирования клонального роста, размножения и изменения фенотипа гепатоцитов in vitro, клетки, фармацевтический состав, способы получения рекомбинантной клетки и генного продукта, способы использования клеток, способ трансплантации гепатоцитов, способ испытания лекарственного препарата, способ поддержания жизнеспособности дифференцированных гепатоцитов | |
| EP0764719A3 (en) | Methods for animal cell culture | |
| NO922887L (no) | Fremgangsmaate for dannelse av cellemasse og/eller fermenteringsprodukter under sterile forhold samt anordning for utfoerelse av fremgangsmaaten | |
| IL94611A0 (en) | Cell culture systems and media | |
| CA2100268A1 (en) | Method for culturing and transforming human stem cell-containing compositions | |
| AU641488B2 (en) | Human hematopoietic stem cell | |
| WO1990015877A3 (en) | Methods, compositions and devices for growing cells | |
| CA2122141A1 (en) | Methods for selectively expanding stem cells | |
| CA2278588A1 (en) | Method for increasing the growth of plant cell cultures | |
| DE69325449T2 (de) | Verfahren zur entwicklung von neuen pflanzentypen mit kapazität zur stickstoffbindung ebenfalls in deren blättern | |
| EP0310056A3 (en) | Thymic stroma-derived t cell growth factor and process for its production | |
| SU803473A1 (ru) | Питательна среда дл выращивани кормовых дрожжей | |
| EP0276154A3 (en) | Method and apparatus for cell culture | |
| Belyanin et al. | Productivity and biochemical composition of Chlorella at different levels of illumination and nitrogen limitation | |
| JPS6475096A (en) | Removal method for tetramethylammonium compound | |
| RU2001123409A (ru) | Способ культивирования микроорганизмов Mycobacterium tuberculosis |